Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViaDerma is a specialty pharmaceutical company that develops and commercializes innovative topical drug delivery solutions. The company's proprietary SkinPass (formerly RAIDS) technology is a transdermal delivery system designed to enhance the penetration of active ingredients through the skin, offering a more effective alternative to traditional topical and oral medications. Its flagship product, Vitastem, is an FDA-registered topical antibiotic that utilizes this technology to treat a variety of skin infections and wounds. ViaDerma is expanding its product portfolio to include treatments for psoriasis, eczema, vitiligo, and pain management, while also pursuing international distribution and licensing opportunities for its delivery platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViaDerma Distribution.